Cargando…

Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly

Detalles Bibliográficos
Autores principales:	TIAN, Zhuang, REN, Chao, HUO, Li, LI, Xiao, WANG, Yi-Ning, HUANG, Lun, TIAN, Ran, ZHANG, Shu-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762698/ https://www.ncbi.nlm.nih.gov/pubmed/33424949 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.12.010

Ejemplares similares

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan
por: Naito, Takanori, et al.
Publicado: (2023)

Transthyretin Cardiac Amyloidosis: Pathogenesis, Treatments, and Emerging Role in Heart Failure with Preserved Ejection Fraction
por: Ton, Van-Khue, et al.
Publicado: (2015)

Wild-type transthyretin amyloidosis in female patients
por: Kristen, Arnt V, et al.
Publicado: (2015)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
por: Coelho, Teresa, et al.
Publicado: (2019)

Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis
por: Martini, Nicolò, et al.
Publicado: (2020)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

Wild-Type Transthyretin Cardiac Amyloidosis in a Transplanted Heart
por: Stern, Lily K., et al.
Publicado: (2023)

Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
por: He, Xinyue, et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2017)

An echo score raises the suspicion of cardiac amyloidosis in Chinese with heart failure with preserved ejection fraction
por: Yang, Hong, et al.
Publicado: (2022)

With M-protein positive, could transthyretin amyloidosis be easily excluded? Not necessarily! Wild-type transthyretin amyloidosis with Waldenström’s macroglobulinaemia: a case report
por: Kinoshita, Haruyuki, et al.
Publicado: (2022)

A case of wild-type transthyretin amyloidosis associated with organizing pneumonia
por: Nakao, Makoto, et al.
Publicado: (2017)

Wild-Type Transthyretin Amyloidosis in Female Patients　― Consideration of Sex Differences ―
por: Ochi, Yuri, et al.
Publicado: (2021)

Prognostic value of exercise echocardiography in patients with wild-type transthyretin amyloidosis
por: Agudo, Cristina Aguilera, et al.
Publicado: (2022)

Multimodality assessments of wild‐type transthyretin cardiac amyloidosis with no ventricular hypertrophy
por: Iwaya, Takuma, et al.
Publicado: (2022)

Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study
por: Liu, Xiao-hang, et al.
Publicado: (2022)

Wild-type Transthyretin Amyloidosis with Diffuse Alveolar-septal Amyloidosis Diagnosed by a Transbronchial Lung Biopsy
por: Ishida, Masaki, et al.
Publicado: (2022)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis
por: Ochi, Yuri, et al.
Publicado: (2020)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
por: Moreno-Gázquez, Inmaculada, et al.
Publicado: (2023)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction
por: Liu, Dan, et al.
Publicado: (2014)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Afshar, Majid, et al.
Publicado: (2012)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis
por: Ihse, Elisabet, et al.
Publicado: (2010)

Wild type transthyretin cardiac amyloidosis in a young individual: A case report
por: Ghosh, Shreya, et al.
Publicado: (2021)

Incidence and predictors of worsening heart failure in patients with wild‐type transthyretin cardiac amyloidosis
por: Ladefoged, Bertil Thyrsted, et al.
Publicado: (2022)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
por: Yamaguchi, Hiroki, et al.
Publicado: (2022)

Recent advances in transthyretin amyloidosis therapy
por: Ueda, Mitsuharu, et al.
Publicado: (2014)

Molecular Tweezers Targeting Transthyretin Amyloidosis
por: Ferreira, Nelson, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nm3a9kjoqv85ij0naab2mt5cqa